The principal findings of our clinical study are that well-treated RA patients, despite low disease activity, have impaired brachial artery FMD and that the presence of the Asp299Gly TLR4 polymorphism is not associated with better endothelial function or lower plasma levels of inflammatory cytokines, adhesion molecules, and MCP-1. Here, CCL2 is linked to rheumatoid arthritis.